Novo Nordisk to Launch Cheaper Insulin Options in U.S.

Drug Industry Daily
A A
Novo Nordisk announced that it will launch half-priced generic versions of its NovoLog and NovoLog Mix in the U.S. in January.

To View This Article:

Login

Subscribe To Drug Industry Daily